Phase 2b study completed in amyotrophic lateral sclerosis (ALS) demonstrated lead asset PrimeC slows disease progression and functional decline Ongoing...
NeuroSense
CAMBRIDGE, Mass., Dec. 18, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company developing novel...
:max_bytes(150000):strip_icc():focal(2999x0:3001x2)/peo-trending-spring-fashion-tout-5ff6cde4c3c94861b3632167699873e8.jpg "Amazon’s Most Popular Spring Fashion Starts at")
